Table 7.

Multivariate regression analysis for predicting eligibility of patients for BCS after neoadjuvant chemotherapy

		B	Std. error	Wald	Sig.	Exp(B)	95% confidence interval for Exp(B)
							Lower bound	Upper bound
BCS	Age	− 0.119	0.036	10.751	0.001*	0.887	0.826	0.953
	Menopause (no)	− 1.256	0.591	4.511	0.034*	0.285	0.089	0.908
	Grade (1vs4)	0.932	0.520	3.215	0.073	2.539	0.917	7.029
	Type (1vs6)	− 0.455	0.507	.803	0.370	0.635	0.235	1.715
	Stage (1vs7)	− 0.362	0.264	1.874	0.171	0.696	0.415	1.169
	ER (no)	− 3.315	1.224	7.339	0.007*	0.036	0.003	0.400
	PR (no)	1.390	0.772	3.241	0.072	4.016	0.884	18.248
	HER2 (no)	0.365	0.748	.237	0.626	1.440	0.332	6.243
	KI67	0.469	0.456	1.056	0.304	1.598	0.654	3.910
	Chemotherapy	− 1.676	0.656	6.538	0.011	0.187	0.052	0.676

The full model is significant at 0.000

*statistically p-value at below 0.05